CRN responds to JAMA Botanical Use Survey
CRN responds to an “original investigation” that appeared in JAMA Open Network (“Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults”).
Supplier News
Edgewell Personal Care announces executive leadership changes
Edgewell Personal Care Company announced key changes to its executive leadership team.
New study uncovers growing ‘sunxiety’ and demand for multi-functional sunscreen
Fear of sun exposure is driving consumers towards costly, environmentally friendly, and multi-functional sunscreen options.
Suni Lee spotted in KISS Salon X-tend Nails at Olympic games
Suni Lee, 2020 Olympic all-around gymnastics champion and brand ambassador for the New KISS Salon X-tend LED Soft Gel System, was spotted competing at the 2024 Olympic games this weekend wearing New KISS Salon X-tend Nails in the style Pure, her favorite go-to look, an almond shaped nail with a Fren
The Hershey’s Store unveils Reese’s Peanut Butter Pumpkins
You may be thinking, “It’s too soon to celebrate Halloween, right?” Well, when there’s Reese’s involved, it’s never too early. The brand is giving chocolate and peanut butter lovers exactly what they deserve with the release of Reese’s Peanut Butter Pumpkins for the first time ever on shop.hersheys.
Sun Pharma receives FDA approval for new alopecia areata treatment
Sun Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. Alopecia areata affects around 700,000 people in the United States, and 300,000 have severe alopecia areata.
OCuSOFT introduces OCuSOFT Retaine Allergy Artificial Tears for eye allergy itch relief
OCuSOFT Inc., a privately-held eye and skin care company with an established reputation for innovation in eyelid hygiene announces the availability of OCuSOFT Retaine Allergy original prescription strength antihistamine tears for eye allergy itch relief.
CHPA joins 17 Health Choices Coalition Members to support Oral Health Products Inclusion Act
WASHINGTON – The Consumer Healthcare Products Association (CHPA) today released the following statement after joining 17 other members of the Health Choices Coalition – a group comprised of healthcare providers, patients, consumers, retailers, manufacturers, pharmacies, insurers, and businesses of a
CHPA recognizes International Self-Care Day
WASHINGTON – The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized an
Eosera’s new foundation and $35,000 pitch competition
FORT WORTH, Texas – In a state ranked fifth best for women-owned startups, the Eosera foundation proudly announces its third annual pitch competition, a dynamic platform designed to propel female-led businesses in Texas to new heights.
Aurobindo gets FDA approval for dutasteride and tamsulosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for dutasteride and tamsulosin hydrochloride capsules 0.5 mg/0.4 mg.
Aurobindo receives FDA approval for baricitinib tablets
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application baricitinib tablets, 1mg and 2mg.